Biotechnology
Sort by: Featured Most recent Most read Most commented
62 results total, viewing 31 - 40
UMass Dartmouth completes first stage of MAB construction
Seven months after the initial groundbreaking, the University of Massachusetts Dartmouth celebrated the end of the first stage of construction of the Massachusetts Accelerator for Biomanufacturing with a “topping off ceremony” on Thursday in Fall River. more
| 12/7/12
UMass Dartmouth professor lands $400K for cell imaging research
Maolin Guo, associate professor of chemistry and biochemistry at the University of Massachusetts Dartmouth, landed a $400,000 research grant from the National Science Foundation to support the development of a molecular imaging probe for cell research. more
| 12/3/12
URI looking to expand Providence presence
The University of Rhode Island plans to increase its presence in the state’s capital city, according to President David M. Dooley, as part of a strategy to better prepare its students for success as well as help Rhode Island’s economy grow out of the hole it is in. more
| 11/28/12
Covidien brain monitor earns nod from NICE
Covidien PLC’s BIS Brain Monitoring System earned a recommendation from the U.K.-based National Institute for health and Clinical Excellence. more
| 11/23/12
Chamber meet focuses on innovation, collaboration
The 2012 meeting of the Greater Providence Chamber of Commerce, held Monday at the R.I. Convention Center, made news that could re-shape the region’s economy. more
| 11/20/12
Covidien earnings rise to $1.9B in 2012
Medical technology maker Covidien PLC reported fourth-quarter earnings of $461 million, or 95 cents per diluted share, a rise of 2.2 percent from the $451 million, or 92 cents per diluted share reported during the same period in 2011. more
| 11/12/12
Amgen places bet on heart drug as rivals go after sales
Amgen Inc., the world’s largest biotechnology company, is developing a new anti-cholesterol medicine by 2015 that it sees as its best shot to offset reduced sales when its popular anemia drugs lose exclusivity. more
EpiVax awarded $55,000 to explore nerve disease treatment
Providence-based EpiVax Inc. was awarded a $55,000 grant from the GBS/CIDP Foundation International to explore using Tregitopes as a new therapy for a nerve disease that is treated currently with intravenous immunoglobulin. more
IlluminOss lets go president and CEO
(Updated, 5:20 p.m.) IlluminOss Medical Inc. terminated President and CEO Scott Rader Monday, company founder Robert Rabiner said Wednesday. more
Amgen sales rise to $4.2B in 3Q
Thousand Oaks, Calif.–based Amgen, one of the world’s largest biotechnology companies, saw revenue rise 9.5 percent to $4.3 billion in the three months ended Sept. 30 from $3.9 billion during the same period in 2011. more
| 10/24/12
« Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 Next »
Calendar
PBN Hosted
Events

Celebrate RI's many exceptional women at PBN's Business Women Awards luncheon May 30th at the Providence Marriott. Reserve your seat today!
Advertisement
National
Local
Latest News